肠道菌群在高血压合并骨质疏松症中的作用

Role of intestinal flora in hypertension complicated with osteoporosis

高血压和骨质疏松症(OP)是中老年人群常见疾病,近年来两者共病患者逐渐增多。由于该病起病隐匿,病至后期则易引起骨折及心脑肾的严重并发症,不仅严重损害患者生活质量,而且增加了临床治疗难度,因此,加强对此病的研究尤为必要。肠道菌群紊乱会导致OP的发生,而高血压患者肠道菌群明显失调。本文认为肠道菌群可能是高血压合并OP的关键影响因素,肠道菌群失调会导致短链脂肪酸代谢失衡、免疫炎症反应和交感神经活性增强,从而致使骨稳态失衡并促进OP的发生,由此提出调节肠道菌群可能是干预高血压合并OP的新途径。

Hypertension and osteoporosis(OP) are common diseases in middle-aged and elderly people,and the number of patients with both diseases has gradually increased in recent years.Because the onset of the disease is hidden,it is easy to cause fractures and serious complications of heart,brain and kidney in the later stage,which not only seriously damages the quality of life of patients,but also increases the difficulty of clinical treatment.Therefore,it is particularly necessary to strengthen the research on this disease.More and more studies have found that the disorder of intestinal flora will lead to the occurrence of OP,while the intestinal flora of patients with hypertension is obviously out of balance.Therefore,this paper thinks that intestinal flora may be the key influencing factor of hypertension complicated with OP,and the imbalance of intestinal flora will lead to the imbalance of short-chain fatty acid metabolism,immune inflammatory reaction and increased sympathetic nerve activity,thus causing the imbalance of bone homeostasis and promoting the occurrence of OP.Therefore,it is suggested that regulating intestinal flora may be a new way to intervene hypertension complicated with OP.